152 related articles for article (PubMed ID: 6155329)
1. Failure of synthetic muramyl dipeptide to increase antibacterial resistance.
Finger H; Wirsing von König CH
Infect Immun; 1980 Feb; 27(2):288-91. PubMed ID: 6155329
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
3. Reversion of dextran sulfate-induced loss of antibacterial resistance by Bordetella pertussis.
Finger H; Heymer B; Wirsing CH; Emmerling P; Hof H
Infect Immun; 1978 Mar; 19(3):950-60. PubMed ID: 640739
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
5. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
6. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS
Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
[TBL] [Abstract][Full Text] [Related]
8. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
9. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
[TBL] [Abstract][Full Text] [Related]
10. Macrophage function in senescence.
Finger H; Heymer B; Wirsing von König CH; Emmerling P
Gerontology; 1982; 28(4):223-32. PubMed ID: 6180958
[TBL] [Abstract][Full Text] [Related]
11. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
12. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
Chedid L; Audibert F; Johnson AG
Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
[No Abstract] [Full Text] [Related]
15. Stimulation of mouse resistance to bacterial infection with muramyl dipeptide glycoside.
Kalyuzhin OV; Kalina NG; Bashtanenko AF; Shkalev MV; Kuzovlev FN; Kalyuzhin VV
Bull Exp Biol Med; 2003 May; 135(5):452-5. PubMed ID: 12910284
[TBL] [Abstract][Full Text] [Related]
16. Effect of cycloalkyl glycosides of muramyl dipeptide on antibacterial resistance of mice and cytokine production by human mononuclear cells.
Kalyuzhin OV; Lobanov DS; Mulik EL; Kimpaeva DS; Zemlyakov AE; Kalina NG; Karaulov AV
Bull Exp Biol Med; 2009 Oct; 148(4):623-6. PubMed ID: 20396756
[TBL] [Abstract][Full Text] [Related]
17. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
18. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
Kireszenbaum F; Ferraresi RW
Infect Immun; 1979 Jul; 25(1):273-8. PubMed ID: 113344
[TBL] [Abstract][Full Text] [Related]
20. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]